The announcement follows growing calls from public health advocates and humanitarian organizations urging the US government to share available supplies of MBP134 to support outbreak control efforts in Central Africa.
The collaboration follows the signing of a Memorandum of Understanding and forms part of Saudi Arabia’s broader efforts to enhance preventive healthcare and improve outcomes for people living with chronic diseases.
The move marks an important step toward evaluating the technology for Good Manufacturing Practice (GMP)-compliant manufacturing while improving the efficiency of producing next-generation medicines.
The acquisition is expected to strengthen Merck’s position in the rapidly growing life sciences sector, particularly in areas such as cell and gene therapy, precision diagnostics, multi-omics research, and biopharmaceutical manufacturing.
The vaccine was registered earlier this month by the South African Health Products Regulatory Authority (SAHPRA), paving the way for large-scale importation and commercial distribution.
The move follows Sanner’s acquisition of Springboard in January 2024 and reflects the company’s goal of building a seamless, end-to-end CDMO platform spanning medical technology, pharmaceuticals, and biotechnology.
The strategy aims to enhance national health security, create jobs, promote innovation, and improve access to quality and affordable healthcare commodities while reducing the country’s reliance on imports.
The healthcare package forms part of a broader set of cooperation agreements covering education, green industry, vocational training, and support for small and medium-sized enterprises.
Japan will channel the support through the International Federation of Red Cross and Red Crescent Societies (IFRC), the World Food Programme (WFP), and the United Nations Children’s Fund (UNICEF).
Moscow researchers developed a series of national standards, known as GOST standards, covering the creation, testing, and clinical use of AI technologies.